Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Flachenecker

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
BMC Sports Science, Medicine & Rehabilitation|April 24, 2025
Internet-based exercise and physical activity promotion for persons with multiple sclerosis: a randomized controlled trialVerena Hartung, Alexander Tallner, Peter Flachenecker, et al.
Der Nervenarzt|January 5, 2021
[Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis]Burkhard Domurath, Peter Flachenecker, Thomas Henze, et al.
Neurology and Therapy|January 12, 2022
Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS RegistryNiklas Frahm, Firas Fneish, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2012
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in GermanyAnke Stroet, Claudia Hemmelmann, Michaela Starck, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS RegistryNiklas Frahm, David Ellenberger, Alexander Stahmann, et al.
Health and Quality of Life Outcomes|October 9, 2023
Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/DAnna Chorschew, Firat Kesgin, Judith Bellmann-Strobl, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple SclerosisJanina Beck, Anke Kirsten Jaekel, Federico Leopoldo Zeller, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 24, 2024
Subgroup analyses and patterns of multiple sclerosis health service utilisation: A cluster analysisLara Marleen Fricke, Kathrin Krüger, Corinna Trebst, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2014
Multiple sclerosis registries in Europe - results of a systematic surveyPeter Flachenecker, Karoline Buckow, Maura Pugliatti, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
BMC Sports Science, Medicine & Rehabilitation|April 24, 2025
Internet-based exercise and physical activity promotion for persons with multiple sclerosis: a randomized controlled trialVerena Hartung, Alexander Tallner, Peter Flachenecker, et al.
Der Nervenarzt|January 5, 2021
[Current aspects of neurogenic dysfunctions of the lower urinary tract in multiple sclerosis]Burkhard Domurath, Peter Flachenecker, Thomas Henze, et al.
Neurology and Therapy|January 12, 2022
Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS RegistryNiklas Frahm, Firas Fneish, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2012
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in GermanyAnke Stroet, Claudia Hemmelmann, Michaela Starck, et al.
Therapeutic Advances in Neurological Disorders|April 1, 2024
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS RegistryNiklas Frahm, David Ellenberger, Alexander Stahmann, et al.
Health and Quality of Life Outcomes|October 9, 2023
Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/DAnna Chorschew, Firat Kesgin, Judith Bellmann-Strobl, et al.
Diagnostics (Basel, Switzerland)|January 21, 2022
Clinical Predictors of Neurogenic Lower Urinary Tract Dysfunction in Persons with Multiple SclerosisJanina Beck, Anke Kirsten Jaekel, Federico Leopoldo Zeller, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 24, 2024
Subgroup analyses and patterns of multiple sclerosis health service utilisation: A cluster analysisLara Marleen Fricke, Kathrin Krüger, Corinna Trebst, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2014
Multiple sclerosis registries in Europe - results of a systematic surveyPeter Flachenecker, Karoline Buckow, Maura Pugliatti, et al.
Pageof 7